Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive Analysis for Clinical Trial Success PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical trials at the upcoming Chief Medical Officer (CMO) Summit 360degree in Boston, MA. https://mma.prnewswire.com/media/2267452/PhaseV_logo.jpg […]

Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing Phase I clinical trial of RAG-01, a first-in-class saRNA therapy for the treatment of non-muscle invasive bladder cancer (NMIBC). The data were presented in a late breaking session by Dr. Paul Anderson

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI) today announced that the Company has expanded its U.S. logistics and warehousing operations to the East Coast market. This significant milestone marks the Company's business expansion from the West Coast to the East Coast, now covering a substantial portion of the U.S. market and laying a solid

(NASDAQ:ASNS), FREMONT, Calif., March 24, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced its financial results for the full year 2024, reporting significant improvements across key financial metrics. The company showed strong performance, with revenue

(NASDAQ:ICON), ATHENS, Greece, March 24, 2025 (GLOBE NEWSWIRE) — Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that it has entered, through a separate wholly-owned subsidiary, into (i) a definitive agreement with

(NASDAQ:NXXT), NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — PRISM MarketView has released an exclusive interview with Michael Farkas, CEO of NextNRG Inc. (NASDAQ: NXXT), highlighting the company's record-breaking growth and its role at the forefront of the AI-powered energy revolution. As global demand for decentralized, sustainable, and intelligent energy solutions increases, NextNRG is pioneering

(TSX-V:SLI),(Boerse Frankfurt – Freiverkehr:S5L),(NYSE MKT:SLI), VANCOUVER, British Columbia, March 24, 2025 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI), a leading near-commercial lithium company, today announced its financial and operating results for the six month fiscal period ended December 31, 2024. “The last year has been crucial for the

Milan, Italy, March 24, 2025 (GLOBE NEWSWIRE) — Salvatore Castagna, a pioneer in financial and technological innovation, has developed a groundbreaking passive income system through advanced devices that can be fully customized for any cryptocurrency. Thanks to this innovation, anyone can generate daily profits simply by keeping the device connected. Designed with cutting-edge technology, the

London, UK, March 24, 2025 (GLOBE NEWSWIRE) — Shiba ZK, the new-generation meme coin, intends to list with an initial coin offering price at $0.001 per coin, increasing to $0.05 on the day the coin goes live, giving the early investors a lot of room for profit. Shiba ZK stands out from other meme tokens

(NASDAQ:BMEA), Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of icovamenib Strong correlation between C-peptide increase and HbA1c reduction (r = -0.73, p<0.0001) across all dosing groups (n=23) support the proposed mechanism of beta cell restoration Best response observed